Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.
Current Team (3)Update
Funding Rounds (3) - $26.4MUpdate
6275 Nancy Ridge Drive
San Diego, CA 92121